Suppr超能文献

中国南方某地级市医院鼻咽癌治疗后的长期生存情况

Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China.

作者信息

Du Yun, Zhang Wentong, Lei Feng, Yu Xia, Li Zhuming, Liu Xiaodong, Ni Yanan, Deng Li, Ji Mingfang

机构信息

Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan 528400, People's Republic of China.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Stockholm, Sweden.

出版信息

Cancer Manag Res. 2020 Feb 24;12:1329-1338. doi: 10.2147/CMAR.S237278. eCollection 2020.

Abstract

PURPOSE

NPC is a malignant and invasive tumor with the incidence rate of 19/100,000 per year in Zhongshan City, a prefecture city in southern China. Long-term survival analysis on intensity-modulated radiotherapy (IMRT)-based treatment in local prefecture-level hospitals have not been investigated. We aimed to evaluate the 5-year clinical outcomes and prognostic factors of NPC treated with IMRT in Zhongshan City People's Hospital (ZSPH), a prefecture-level hospital in South China.

PATIENTS AND METHODS

The number of 149 newly diagnosed non-metastatic NPC cases treated with IMRT were included from Zhongshan City People's Hospital between January 2010 and December 2011. The survival outcomes, treatment toxicities and prognostic factors were analyzed by Kaplan-Meier method and Cox proportional hazards model.

RESULTS

With a median follow-up period of 65 months for the cohort, the 5-year local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant metastasis-free survival (DMFS) and overall survival (OS) were 86.80%, 94.80%, 86.10% and 80.50%, respectively. The 5-year OS rates were 100%, 95.2%, 87% and 67.2% for stage I, II, II and IVa-b, respectively (P=0.004). The 5-year LRFS rates were 97.2%, 96.0%, 90.4% and 72.0% for T1, T2, T3 and T4, respectively (P=0.001); the 5-year DMFS rates were 100% for T1, 96.8% for T2, 81.9% for T3 and 74.6% for T4 (P=0.022). A multivariate analysis revealed tumor stage as an independent prognostic factor for LRFS, DMFS and OS. No patients died from acute toxicities. Late toxicities were observed for 130 (87.2%) patients, and most late toxicities were graded I/II.

CONCLUSION

NPC treatment effect in a prefecture-level hospital in South China was comparable to international results and toxicities were tolerable. Tumour stage was an independent prognostic factor for survival outcome. More NPC survival data from local and remote places are needed.

摘要

目的

鼻咽癌是一种恶性侵袭性肿瘤,在中国南方地级市中山市的年发病率为19/10万。尚未对当地地级市医院基于调强放射治疗(IMRT)的治疗进行长期生存分析。我们旨在评估在中国南方地级市医院中山市人民医院(ZSPH)接受IMRT治疗的鼻咽癌患者的5年临床结局和预后因素。

患者与方法

纳入2010年1月至2011年12月期间在中山市人民医院新诊断的149例接受IMRT治疗的非转移性鼻咽癌患者。采用Kaplan-Meier法和Cox比例风险模型分析生存结局、治疗毒性和预后因素。

结果

该队列的中位随访期为65个月,5年局部无复发生存率(LRFS)、区域无复发生存率(RRFS)、远处无转移生存率(DMFS)和总生存率(OS)分别为86.80%、94.80%、86.10%和80.50%。I、II、III和IVa-b期患者的5年OS率分别为100%、95.2%、87%和67.2%(P = 0.004)。T1、T2、T3和T4期患者的5年LRFS率分别为97.2%、96.0%、90.4%和72.0%(P = 0.001);T1、T2、T3和T4期患者的5年DMFS率分别为100%、96.8%、81.9%和74.6%(P = 0.022)。多因素分析显示肿瘤分期是LRFS、DMFS和OS的独立预后因素。无患者死于急性毒性。130例(87.2%)患者出现晚期毒性,大多数晚期毒性为I/II级。

结论

中国南方一家地级市医院的鼻咽癌治疗效果与国际结果相当,毒性可耐受。肿瘤分期是生存结局的独立预后因素。需要更多来自本地和偏远地区的鼻咽癌生存数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9e/7047969/5c70507acbb1/CMAR-12-1329-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验